Shariat SF - Search Results

1

The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis.

Mertens LS, Claps F, Mayr R, Hodgson A, Shariat SF, Hippe K, Neuzillet Y, Sanders J, Burger M, Pouessel D, Otto W, van der Kwast TH, Lotan Y, Allory Y, Downes MR, van Rhijn BWG. Mertens LS, et al. Among authors: shariat sf. Int J Surg Pathol. 2023 Apr;31(2):157-166. doi: 10.1177/10668969221095173. Epub 2022 Apr 24. Int J Surg Pathol. 2023. PMID: 35466737 Free article.

2

Survivin expression is associated with features of biologically aggressive prostate carcinoma.

Shariat SF, Lotan Y, Saboorian H, Khoddami SM, Roehrborn CG, Slawin KM, Ashfaq R. Shariat SF, et al. Cancer. 2004 Feb 15;100(4):751-7. doi: 10.1002/cncr.20039. Cancer. 2004. PMID: 14770431 Free article.

3

The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.

Lotan Y, Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Cadeddu JA, Sagalowsky AI, McConnell JD, Roehrborn CG. Lotan Y, et al. Among authors: shariat sf. J Urol. 2004 Jun;171(6 Pt 1):2209-14. doi: 10.1097/01.ju.0000127730.78973.fe. J Urol. 2004. PMID: 15126787

4

Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.

Khoddami SM, Shariat SF, Lotan Y, Saboorian H, McConnell JD, Sagalowsky AI, Roehrborn CG, Koeneman KS. Khoddami SM, et al. Among authors: shariat sf. BJU Int. 2004 Jul;94(1):42-6. doi: 10.1111/j.1464-410X.2004.04898.x. BJU Int. 2004. PMID: 15217428

5

Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.

Shariat SF, Herman MP, Casella R, Lotan Y, Karam JA, Stenman UH. Shariat SF, et al. Eur Urol. 2005 Sep;48(3):424-31. doi: 10.1016/j.eururo.2005.04.034. Eur Urol. 2005. PMID: 15963628

6

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

Shariat SF, Ashfaq R, Roehrborn CG, Slawin KM, Lotan Y. Shariat SF, et al. J Urol. 2005 Nov;174(5):2046-50. doi: 10.1097/01.ju.0000176459.79180.d1. J Urol. 2005. PMID: 16217391

7

Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor.

Shariat SF, Duchene D, Kabbani W, Mucher Z, Lotan Y. Shariat SF, et al. Urology. 2005 Dec;66(6):1319. doi: 10.1016/j.urology.2005.06.102. Urology. 2005. PMID: 16360470

8

Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.

Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y. Shariat SF, et al. Eur Urol. 2006 Feb;49(2):293-302. doi: 10.1016/j.eururo.2005.10.027. Epub 2005 Dec 20. Eur Urol. 2006. PMID: 16387412

9

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.

Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF. Svatek RS, et al. Among authors: shariat sf. Cancer. 2006 Apr 15;106(8):1701-7. doi: 10.1002/cncr.21795. Cancer. 2006. PMID: 16541433 Free article.

10

Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.

Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y. Shariat SF, et al. Eur Urol. 2007 Jan;51(1):137-49; discussion 149-51. doi: 10.1016/j.eururo.2006.05.021. Epub 2006 Jun 8. Eur Urol. 2007. PMID: 16793197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,922 results

Search Page

Filters